Jingzhan Lu

A PhD student with a passion for Computational Genetics of Healthcare 🧬

Recent News

  [1]. European Society of Human Genetics 2025 (ESHG 2025 @Milan): Oral Presentaion @European conference fellowship

• 11:00-12:30, Tuesday, 27 May - @ESHG Info - C34.Advancing cancer prevention, detection and treatment
• Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS)
  

  [2]. Cancer in Primary Care Research International (Ca-PRI) Conference 2025: Oral Presentaion @Manchester

• In Coming Soon - @April 2025, Ca-PRI Info
• Combing the PSA test with Polygenic Risk Scores (PRS/GRS) to improve the prostate cancer diagnosis and prediction in primary care
  

  [3]. UK Biobank Scientific Conference 2024: Poster Presentaion @London

• Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS) in the UK Biobank
  

  [4]. European Society of Human Genetics 2024 (ESHG 2024 @Berlin)：Poster Presentaion

• Impact of control selection strategies on GWAS results: a study of Schizophrenia and Bipolar Disorder in the UK Biobank
  
• P17.015.D - Poster Viewing Group D, Abstract available @ESHG Info
  

Click to Connect   @JingzhanLu

Education

• University of Exeter (Medical School)             10/2023 - Now
  
  • PhD Genetics and Genomics
  • Genetics of Complex Traits Research Group
    
• University College London (UCL)                  09/2021 - 12/2022
  
  • MSc Health Data Science
  • Human Genetics @UCL Lab
• Taiwan Tzu Chi University（College of Medicine）       09/2017 - 07/2021
  
  • BEng Medical Informatics (Bioinfor Track)

Research

• Predicting Prostate Cancer by combining prostate-specific antigen (PSA) test results with Genetic Risk Scores (GRS)

• Impact of control selection strategies on GWAS results – a study of the Schizophrenia and Bipolar Disorder in the UK Biobank (Available on ResearchGate)
  
                                                                  Manhattan-Comparison Plot
  
  
• To develop a platform for the identification of Gram-stained images using Deep Convolutional Neutral Network
  
• Molecular docking analysis of Ritonavir, Lopinavir, Atazanavir, Darunavir and TMC-31091 as SARS-CoV-2 3CLpro inhibitors
  
                  

  Social Media

  I can be found on the following creative platforms：

• ResearchGate：Jingzhan Lu
• LinkedIn：Jingzhan Lu
• Instagram：lujingzhan

  Conference and Talk

• ESHG 2024, European Human Genetics Conference 2024, Berlin, Germany
• SGGD 2024, Genetics of Diabetes, University of Exeter, UK
• 2022 AI-DLDA Summer School, University of Udine, Italy：YouTube Video

  Contact

• Email: 106316153@gms.tcu.edu.tw